Skip to main content Accessibility help
×
Home

Antimicrobial prescribing in patients with advanced-stage illness in the antimicrobial stewardship era

  • Yasuaki Tagashira (a1), Kanae Kawahara (a1), Akane Takamatsu (a1) and Hitoshi Honda (a1)

Abstract

Objective

Antimicrobials are frequently administered to patients with an advanced-stage illness. Understanding the current practice of antimicrobial use at the end of life and the factors influencing physicians’ prescribing behavior is necessary to develop an effective antimicrobial stewardship program and to provide optimal end-of-life care for terminally ill patients.

Design

A 1-year retrospective cohort study.

Setting

A public tertiary-care center.

Patients

The study included 260 adult patients who were hospitalized and later died at the study institution with an advanced-stage illness.

Results

Of 260 patients in our study cohort, 192 (73.8%) had an advanced-stage malignancy and 136 (52.3%) received antimicrobial therapy in the last 14 days of their life; of the latter, 60 (44.1%) received antimicrobials for symptom relief. Overall antimicrobial use in the last 14 days of life was 421.9 days of therapy per 1,000 patient days. Factors associated with antimicrobial use in this period included a history of antimicrobial use prior to the last 14 days of life during index hospitalization (adjusted odds ratio [aOR], 4.86; 95% confidence interval [CI], 2.67–8.84) and antipyretic use in the last 14 days of life (aOR, 4.19; 95% CI, 2.01–8.71).

Conclusion

Approximately half of the patients hospitalized with an advanced-stage illness received antimicrobials in the last 14 days of life. The factors associated with antimicrobial use at the end of life in this study are likely to explain physicians’ prescribing behaviors. In the current era of antimicrobial stewardship, reconsidering antimicrobial use in terminally ill patients is necessary.

Copyright

Corresponding author

Author for correspondence: Hitoshi Honda, MD, Division of Infectious Diseases, Tokyo Metropolitan Tama Medical Center, 2-8-29, Musashidai, Fuchu, Tokyo, 183-8524, Japan. E-mail: hhhhonda@gmail.com

References

Hide All
1. Hecker, MT, Aron, DC, Patel, NP, Lehmann, MK, Donskey, CJ. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med 2003;163:972978.
2. Holmes, AH, Moore, LS, Sundsfjord, A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet 2016;387:176187.
3. Tamma, PD, Avdic, E, Li, DX, Dzintars, K, Cosgrove, SE. Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med 2017;177:13081315.
4. Bell, BG, Schellevis, F, Stobberingh, E, Goossens, H, Pringle, M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis 2014;14:13.
5. Lawrence, KL, Kollef, MH. Antimicrobial stewardship in the intensive care unit: advances and obstacles. Am J Respir Crit Care Med 2009;179:434438.
6. Horikoshi, Y, Kaneko, T, Morikawa, Y, et al. The North Wind and the Sun: pediatric antimicrobial stewardship program combining restrictive and persuasive approaches in hematology-oncology ward and hematopoietic stem cell transplant unit. Pediatr Infect Dis J 2018;37:164168.
7. Furuno, JP, Noble, BN, Fromme, EK. Should we refrain from antibiotic use in hospice patients? Expert Rev Anti Infect Ther 2016;14:277280.
8. Mitchell, SL, Shaffer, ML, Loeb, MB, et al. Infection management and multidrug-resistant organisms in nursing home residents with advanced dementia. JAMA Intern Med 2014;174:16601667.
9. Givens, JL, Jones, RN, Shaffer, ML, Kiely, DK, Mitchell, SL. Survival and comfort after treatment of pneumonia in advanced dementia. Arch Intern Med 2010;170:11021107.
10. Metra, M, Ponikowski, P, Dickstein, K, et al. Advanced chronic heart failure: a position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2007;9:684694.
11. Marciniuk, DD, Goodridge, D, Hernandez, P, et al. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline. Can Respir J 2011;18:6978.
12. Janssen, DJA, Spruit, MA, Schols, J, et al. Predicting changes in preferences for life-sustaining treatment among patients with advanced chronic organ failure. Chest 2012;141:12511259.
13. Andrassy, KM. Comments on 'KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int 2013;84:622623.
14. Reisberg, B, Ferris, SH, de Leon, MJ, Crook, T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:11361139.
15. Salpeter, SR, Luo, EJ, Malter, DS, Stuart, B. Systematic review of noncancer presentations with a median survival of 6 months or less. Am J Med 2012;125:e511e516.
16. NCI Dictionary of Cancer Terms. National Cancer Institute website. https://www.cancer.gov/publications/dictionaries/cancer-terms?CdrID=478743. Accessed March 30, 2018.
17. D'Agata, E, Mitchell, SL. Patterns of antimicrobial use among nursing home residents with advanced dementia. Arch Intern Med 2008;168:357362.
18. Charlson, ME, Pompei, P, Ales, KL, MacKenzie, CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373383.
19. Lau, KS, Tse, DM, Tsan Chen, TW, Lam, PT, Lam, WM, Chan, KS. Comparing noncancer and cancer deaths in Hong Kong: a retrospective review. J Pain Symptom Manage 2010;40:704714.
20. Albrecht, JS, McGregor, JC, Fromme, EK, Bearden, DT, Furuno, JP. A nationwide analysis of antibiotic use in hospice care in the final week of life. J Pain Symptom Manage 2013;46:483490.
21. Ahronheim, JC, Morrison, RS, Baskin, SA, Morris, J, Meier, DE. Treatment of the dying in the acute care hospital. Advanced dementia and metastatic cancer. Arch Intern Med 1996;156:20942100.
22. Nakagawa, S, Toya, Y, Okamoto, Y, et al. Can anti-infective drugs improve the infection-related symptoms of patients with cancer during the terminal stages of their lives? J Palliat Med 2010;13:535540.
23. Ramadas, L, Feijo Barroso, P. High frequency of antimicrobials use in palliative care: are we moving in the right direction? J Palliat Med 2017;20:218219.
24. Tse, DM, Chan, KS, Lam, WM, Leu, K, Lam, PT. The impact of palliative care on cancer deaths in Hong Kong: a retrospective study of 494 cancer deaths. Palliat Med 2007;21:425433.
25. Juthani-Mehta, M, Malani, PN, Mitchell, SL. Antimicrobials at the end of life: an opportunity to improve palliative care and infection management. JAMA 2015;314:20172018.
26. Baghban, A, Juthani-Mehta, M. Antimicrobial use at the end of life. Infect Dis Clin North Am 2017;31:639647.
27. Rosenberg, JH, Albrecht, JS, Fromme, EK, et al. Antimicrobial use for symptom management in patients receiving hospice and palliative care: a systematic review. J Palliat Med 2013;16:15681574.
28. Vitetta, L, Kenner, D, Sali, A. Bacterial infections in terminally ill hospice patients. J Pain Symptom Manage 2000;20:326334.
29. Oh, DY, Kim, JH, Kim, DW, et al. Antibiotic use during the last days of life in cancer patients. Eur J Cancer Care (Engl) 2006;15:7479.
30. Mirhosseini, M, Oneschuk, D, Hunter, B, Hanson, J, Quan, H, Amigo, P. The role of antibiotics in the management of infection-related symptoms in advanced cancer patients. J Palliat Care 2006;22:6974.
31. Helde-Frankling, M, Bergqvist, J, Bergman, P, Bjorkhem-Bergman, L. Antibiotic treatment in end-of-life cancer patients-a retrospective observational study at a palliative care center in Sweden. Cancers (Basel) 2016;8:84.
32. White, PH, Kuhlenschmidt, HL, Vancura, BG, Navari, RM. Antimicrobial use in patients with advanced cancer receiving hospice care. J Pain Symptom Manag 2003;25:438443.
33. Reinbolt, RE, Shenk, AM, White, PH, Navari, RM. Symptomatic treatment of infections in patients with advanced cancer receiving hospice care. J Pain Symptom Manage 2005;30:175182.
34. Morgan, DJ, Malani, P, Diekema, DJ. Diagnostic stewardship-leveraging the laboratory to improve antimicrobial use. JAMA 2017;318:607608.
35. Teixeira Rodrigues, A, Roque, F, Falcao, A, Figueiras, A, Herdeiro, MT. Understanding physician antibiotic prescribing behaviour: a systematic review of qualitative studies. Int J Antimicrob Agents 2013;41:203212.
36. Cho, H, Klabunde, CN, Yabroff, KR, et al. Comorbidity-adjusted life expectancy: a new tool to inform recommendations for optimal screening strategies. Ann Intern Med 2013;159:667676.
37. Heyland, DK, Barwich, D, Pichora, D, et al. Failure to engage hospitalized elderly patients and their families in advance care planning. JAMA Intern Med 2013;173:778787.
38. van der Steen, JT, Ooms, ME, van der Wal, G, Ribbe, MW. Withholding or starting antibiotic treatment in patients with dementia and pneumonia: prediction of mortality with physicians' judgment of illness severity and with specific prognostic models. Med Decis Making 2005;25:210221.
39. Yao, CA, Hsieh, MY, Chiu, TY, et al. Wishes of patients with terminal cancer and influencing factors toward the use of antibiotics in Taiwan. Am J Hosp Palliat Care 2015;32:537543.
Type Description Title
WORD
Supplementary materials

Tagashira et al. supplementary material
Appendix

 Word (37 KB)
37 KB

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed